サマリー

イルベサルタンは、高血圧症や糖尿病性腎症の治療に用いられるアンジオテンシン受容体拮抗薬（ARB）です。イルベサルタンは、高血圧症および糖尿病性腎症の治療に用いられるアンジオテンシン受容体拮抗薬（ARB）であり、単剤療法でコントロール不良またはコントロールが期待できない患者に対して、ヒドロクロロチアジドとの併用療法としても使用されます。

市場分析と洞察。イルベサルタンの世界と日本の市場
本レポートは、イルベサルタンの世界および日本市場に焦点を当てています。
2020年のイルベサルタンの世界市場規模はXX百万米ドルで、2021-2027年の間にXX％の年率で推移し、2027年末にはXX百万米ドルに達すると予想されています。日本におけるイルベサルタンの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルになると予測され、予測期間中にXX％のCAGRで成長すると見込まれています。

イルベサルタンの世界市場の範囲と市場規模
イルベサルタン市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のイルベサルタン市場に参加するプレイヤー、ステークホルダーなどは、本レポートを強力なリソースとして活用することで、優位に立つことができます。セグメント別分析では、2016年から2027年までの地域（国）別、タイプ別、アプリケーション別の収益と予測に焦点を当てています。
日本市場では、2016-2027年のイルベサルタンの市場規模を、プレイヤー別、タイプ別、アプリケーション別に分析しています。主要プレイヤーには、日本で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれます。

タイプ別セグメント
配合剤
処方薬

用途別セグメント
高脂血症
高血圧症
心不全
腎臓病
線維性細動
その他

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

会社別
Teva
サノフィ
BMS
大日本住友製薬
ノバルティス
塩野義製薬
ハナル
タジ・ファーマシューティカルズ
アポテックス
江蘇省Hengrui Medicine
ヴァーダントライフサイエンス
アンギータ・ファーマ
オーロ・ファーマ
アバンストラ
珠海ランデュ・ファーマ
Xiansheng製薬
CTTQ
天津恵仁製薬
江蘇万高製薬
浙江華海製薬
浙江愛諾製薬
元和製薬

ページTOPに戻る

目次

1 Study Coverage
1.1 Irbesartan Product Introduction
1.2 Market by Type
1.2.1 Global Irbesartan Market Size Growth Rate by Type
1.2.2 Combination Drugs
1.2.3 Prescribed Drugs
1.3 Market by Application
1.3.1 Global Irbesartan Market Size Growth Rate by Application
1.3.2 Hyperlipidemia
1.3.3 High Blood Pressure
1.3.4 Heart Failure
1.3.5 Kidney Disease
1.3.6 Fibrous Fibrillation
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Irbesartan Market Size, Estimates and Forecasts
2.1.1 Global Irbesartan Revenue 2016-2027
2.1.2 Global Irbesartan Sales 2016-2027
2.2 Global Irbesartan, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Irbesartan Historical Market Size by Region (2016-2021)
2.3.1 Global Irbesartan Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Irbesartan Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Irbesartan Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Irbesartan Sales Forecast by Region (2022-2027)
2.4.2 Global Irbesartan Revenue Forecast by Region (2022-2027)

3 Global Irbesartan Competitor Landscape by Players
3.1 Global Top Irbesartan Manufacturers by Sales
3.1.1 Global Irbesartan Sales by Manufacturer (2016-2021)
3.1.2 Global Irbesartan Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Irbesartan Manufacturers by Revenue
3.2.1 Key Irbesartan Manufacturers Covered: Ranking by Revenue
3.2.2 Global Irbesartan Revenue by Manufacturers (2016-2021)
3.2.3 Global Irbesartan Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Irbesartan Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Irbesartan Revenue in 2020
3.2.6 Global Irbesartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Irbesartan Price by Manufacturers
3.4 Global Irbesartan Manufacturing Base Distribution, Product Types
3.4.1 Irbesartan Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Irbesartan Product Type
3.4.3 Date of International Manufacturers Enter into Irbesartan Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Irbesartan Market Size by Type (2016-2021)
4.1.1 Global Irbesartan Sales by Type (2016-2021)
4.1.2 Global Irbesartan Revenue by Type (2016-2021)
4.1.3 Irbesartan Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Irbesartan Market Size Forecast by Type (2022-2027)
4.2.1 Global Irbesartan Sales Forecast by Type (2022-2027)
4.2.2 Global Irbesartan Revenue Forecast by Type (2022-2027)
4.2.3 Irbesartan Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Irbesartan Market Size by Application (2016-2021)
5.1.1 Global Irbesartan Sales by Application (2016-2021)
5.1.2 Global Irbesartan Revenue by Application (2016-2021)
5.1.3 Irbesartan Price by Application (2016-2021)
5.2 Irbesartan Market Size Forecast by Application (2022-2027)
5.2.1 Global Irbesartan Sales Forecast by Application (2022-2027)
5.2.2 Global Irbesartan Revenue Forecast by Application (2022-2027)
5.2.3 Global Irbesartan Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Irbesartan Market Size YoY Growth 2016-2027
6.1.1 Japan Irbesartan Sales YoY Growth 2016-2027
6.1.2 Japan Irbesartan Revenue YoY Growth 2016-2027
6.1.3 Japan Irbesartan Market Share in Global Market 2016-2027
6.2 Japan Irbesartan Market Size by Players (International and Local Players)
6.2.1 Japan Top Irbesartan Players by Sales (2016-2021)
6.2.2 Japan Top Irbesartan Players by Revenue (2016-2021)
6.3 Japan Irbesartan Historic Market Review by Type (2016-2021)
6.3.1 Japan Irbesartan Sales Market Share by Type (2016-2021)
6.3.2 Japan Irbesartan Revenue Market Share by Type (2016-2021)
6.3.3 Japan Irbesartan Price by Type (2016-2021)
6.4 Japan Irbesartan Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Irbesartan Sales Forecast by Type (2022-2027)
6.4.2 Japan Irbesartan Revenue Forecast by Type (2022-2027)
6.4.3 Japan Irbesartan Price Forecast by Type (2022-2027)
6.5 Japan Irbesartan Historic Market Review by Application (2016-2021)
6.5.1 Japan Irbesartan Sales Market Share by Application (2016-2021)
6.5.2 Japan Irbesartan Revenue Market Share by Application (2016-2021)
6.5.3 Japan Irbesartan Price by Application (2016-2021)
6.6 Japan Irbesartan Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Irbesartan Sales Forecast by Application (2022-2027)
6.6.2 Japan Irbesartan Revenue Forecast by Application (2022-2027)
6.6.3 Japan Irbesartan Price Forecast by Application (2022-2027)

7 North America
7.1 North America Irbesartan Market Size YoY Growth 2016-2027
7.2 North America Irbesartan Market Facts & Figures by Country
7.2.1 North America Irbesartan Sales by Country (2016-2021)
7.2.2 North America Irbesartan Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Irbesartan Market Size YoY Growth 2016-2027
8.2 Asia Pacific Irbesartan Market Facts & Figures by Region
8.2.1 Asia Pacific Irbesartan Sales by Region (2016-2021)
8.2.2 Asia Pacific Irbesartan Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Irbesartan Market Size YoY Growth 2016-2027
9.2 Europe Irbesartan Market Facts & Figures by Country
9.2.1 Europe Irbesartan Sales by Country (2016-2021)
9.2.2 Europe Irbesartan Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Irbesartan Market Size YoY Growth 2016-2027
10.2 Latin America Irbesartan Market Facts & Figures by Country
10.2.1 Latin America Irbesartan Sales by Country (2016-2021)
10.2.2 Latin America Irbesartan Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Irbesartan Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Irbesartan Market Facts & Figures by Country
11.2.1 Middle East and Africa Irbesartan Sales by Country (2016-2021)
11.2.2 Middle East and Africa Irbesartan Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Description and Business Overview
12.1.3 Teva Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Irbesartan Products Offered
12.1.5 Teva Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Description and Business Overview
12.2.3 Sanofi Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi Irbesartan Products Offered
12.2.5 Sanofi Recent Development
12.3 BMS
12.3.1 BMS Corporation Information
12.3.2 BMS Description and Business Overview
12.3.3 BMS Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.3.4 BMS Irbesartan Products Offered
12.3.5 BMS Recent Development
12.4 Sumitomo Dainippon Pharma
12.4.1 Sumitomo Dainippon Pharma Corporation Information
12.4.2 Sumitomo Dainippon Pharma Description and Business Overview
12.4.3 Sumitomo Dainippon Pharma Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sumitomo Dainippon Pharma Irbesartan Products Offered
12.4.5 Sumitomo Dainippon Pharma Recent Development
12.5 Novartis
12.5.1 Novartis Corporation Information
12.5.2 Novartis Description and Business Overview
12.5.3 Novartis Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Novartis Irbesartan Products Offered
12.5.5 Novartis Recent Development
12.6 Shionogi
12.6.1 Shionogi Corporation Information
12.6.2 Shionogi Description and Business Overview
12.6.3 Shionogi Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Shionogi Irbesartan Products Offered
12.6.5 Shionogi Recent Development
12.7 Hanall
12.7.1 Hanall Corporation Information
12.7.2 Hanall Description and Business Overview
12.7.3 Hanall Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hanall Irbesartan Products Offered
12.7.5 Hanall Recent Development
12.8 Taj Pharmaceuticals
12.8.1 Taj Pharmaceuticals Corporation Information
12.8.2 Taj Pharmaceuticals Description and Business Overview
12.8.3 Taj Pharmaceuticals Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Taj Pharmaceuticals Irbesartan Products Offered
12.8.5 Taj Pharmaceuticals Recent Development
12.9 Apotex
12.9.1 Apotex Corporation Information
12.9.2 Apotex Description and Business Overview
12.9.3 Apotex Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Apotex Irbesartan Products Offered
12.9.5 Apotex Recent Development
12.10 Jiangsu Hengrui Medicine
12.10.1 Jiangsu Hengrui Medicine Corporation Information
12.10.2 Jiangsu Hengrui Medicine Description and Business Overview
12.10.3 Jiangsu Hengrui Medicine Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Jiangsu Hengrui Medicine Irbesartan Products Offered
12.10.5 Jiangsu Hengrui Medicine Recent Development
12.11 Teva
12.11.1 Teva Corporation Information
12.11.2 Teva Description and Business Overview
12.11.3 Teva Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Teva Irbesartan Products Offered
12.11.5 Teva Recent Development
12.12 Angita Pharma
12.12.1 Angita Pharma Corporation Information
12.12.2 Angita Pharma Description and Business Overview
12.12.3 Angita Pharma Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Angita Pharma Products Offered
12.12.5 Angita Pharma Recent Development
12.13 Auro Pharma
12.13.1 Auro Pharma Corporation Information
12.13.2 Auro Pharma Description and Business Overview
12.13.3 Auro Pharma Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Auro Pharma Products Offered
12.13.5 Auro Pharma Recent Development
12.14 Avanstra
12.14.1 Avanstra Corporation Information
12.14.2 Avanstra Description and Business Overview
12.14.3 Avanstra Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Avanstra Products Offered
12.14.5 Avanstra Recent Development
12.15 Zhuhai Rundu Pharma
12.15.1 Zhuhai Rundu Pharma Corporation Information
12.15.2 Zhuhai Rundu Pharma Description and Business Overview
12.15.3 Zhuhai Rundu Pharma Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Zhuhai Rundu Pharma Products Offered
12.15.5 Zhuhai Rundu Pharma Recent Development
12.16 Xiansheng Pharmaceutical
12.16.1 Xiansheng Pharmaceutical Corporation Information
12.16.2 Xiansheng Pharmaceutical Description and Business Overview
12.16.3 Xiansheng Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Xiansheng Pharmaceutical Products Offered
12.16.5 Xiansheng Pharmaceutical Recent Development
12.17 CTTQ
12.17.1 CTTQ Corporation Information
12.17.2 CTTQ Description and Business Overview
12.17.3 CTTQ Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.17.4 CTTQ Products Offered
12.17.5 CTTQ Recent Development
12.18 Tianjin Huairen Pharmaceutical
12.18.1 Tianjin Huairen Pharmaceutical Corporation Information
12.18.2 Tianjin Huairen Pharmaceutical Description and Business Overview
12.18.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Tianjin Huairen Pharmaceutical Products Offered
12.18.5 Tianjin Huairen Pharmaceutical Recent Development
12.19 Jiangsu Wangao Pharmaceutical
12.19.1 Jiangsu Wangao Pharmaceutical Corporation Information
12.19.2 Jiangsu Wangao Pharmaceutical Description and Business Overview
12.19.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Jiangsu Wangao Pharmaceutical Products Offered
12.19.5 Jiangsu Wangao Pharmaceutical Recent Development
12.20 Zhejiang Huahai Pharmaceutical
12.20.1 Zhejiang Huahai Pharmaceutical Corporation Information
12.20.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
12.20.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Zhejiang Huahai Pharmaceutical Products Offered
12.20.5 Zhejiang Huahai Pharmaceutical Recent Development
12.21 Zhejiang Ainuo Pharmaceutical
12.21.1 Zhejiang Ainuo Pharmaceutical Corporation Information
12.21.2 Zhejiang Ainuo Pharmaceutical Description and Business Overview
12.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Zhejiang Ainuo Pharmaceutical Products Offered
12.21.5 Zhejiang Ainuo Pharmaceutical Recent Development
12.22 Yuanhe Pharmaceutical
12.22.1 Yuanhe Pharmaceutical Corporation Information
12.22.2 Yuanhe Pharmaceutical Description and Business Overview
12.22.3 Yuanhe Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Yuanhe Pharmaceutical Products Offered
12.22.5 Yuanhe Pharmaceutical Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Irbesartan Industry Trends
13.2 Irbesartan Market Drivers
13.3 Irbesartan Market Challenges
13.4 Irbesartan Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Irbesartan Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer